LBA Wealth Management »

Biosante Pharmaceuticals shares owned by LBA Wealth Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by LBA Wealth Management from 13F filings

Historical chart of LBA Wealth Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by LBA Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by LBA Wealth Management

Quarter filed Position value Share count Share price at filing
2017-03-31 $6.0k 125 48.00
2016-12-31 $8.0k 125 64.00
2016-09-30 $22k 325 67.69

More positions owned by LBA Wealth Management

Vanguard Total Bond Market ETF (BND)
SPDR S&P MidCap 400 ETF (MDY)
Vanguard Short Term Corporate Bond ETF (VCSH)
iShares S&P MidCap 400 Index (IJH)
Vanguard Emerging Markets ETF (VWO)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Nuveen Barclays Shrt Term Muni bdfund (SHM)
iShares Lehman Aggregate Bond (AGG)
iShares MSCI EAFE Index Fund (EFA)
Apple (AAPL)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)

View all positions for LBA Wealth Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Goldman Sachs Group
State Street Corporation
Dimensional Fund Advisors
Ranger Investment Management
Jpmorgan Chase & Co
Citadel Advisors
Global Alpha Capital Management
Millennium Management
Deep Track Capital
Macquarie Group
William Blair Investment Management
Tang Capital Management
Geode Capital Management

View all funds holding Biosante Pharmaceuticals